![Shobhit Dhawan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Shobhit Dhawan is currently Managing Director at Oncode BV and Member of the Supervisory Board at Flindr Therapeutics BV.
Formerly, Mr. Dhawan was Investment Manager at AMC Ventures Holding BV from 2015 to 2019.
Actieve functies van Shobhit Dhawan
| Bedrijven | Functie | Begin |
|---|---|---|
Immagene BV
 Immagene BV Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer patients | Directeur/Bestuurslid | - |
Oncode BV
 Oncode BV Investment ManagersFinance Oncode invests in companies located in the Neherlands. The firm focuses on the health sector of oncology. It participates in equity and debt in pre-seed and seed transactions | Private Equity Investor | - |
Eerdere bekende functies van Shobhit Dhawan
| Bedrijven | Functie | Einde |
|---|---|---|
AMC Ventures Holding BV
 AMC Ventures Holding BV Investment ManagersFinance AMC Ventures invests in companies located in the Netherlands. It participates in seed stage transactions and focuses on sectors such as Health Technology and Health Services. | Private Equity Investor | 01-04-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
AMC Ventures Holding BV
AMC Ventures Holding BV Investment ManagersFinance AMC Ventures invests in companies located in the Netherlands. It participates in seed stage transactions and focuses on sectors such as Health Technology and Health Services. | Finance |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer patients | Health Technology |
Oncode BV
Oncode BV Investment ManagersFinance Oncode invests in companies located in the Neherlands. The firm focuses on the health sector of oncology. It participates in equity and debt in pre-seed and seed transactions | Finance |
